摘要 |
The present invention relates to compounds of the Formula wherein R<SUP>1</SUP>, R<SUP>1a</SUP>, R<SUP>1b</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP>, R<SUP>5</SUP>, R<SUP>6</SUP>, R<SUP>7</SUP>, R<SUP>8</SUP>, R<SUP>9</SUP>, R<SUP>10</SUP>, R<SUP>11</SUP>, R<SUP>12</SUP>, X, Y, Z and n are as defined. Compounds of the Formula I have activity inhibiting production of Abeta-peptide. This invention also relates to pharmaceutical compositions and methods of treating diseases, for example, neurodegenerative diseases, e.g., Alzheimer's disease, in a mammal comprising compounds of the Formula I.
|